Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma

被引：0
|
作者：
Anne von Mässenhausen
Mario Deng
Hannah Billig
Angela Queisser
Wenzel Vogel
Glen Kristiansen
Andreas Schröck
Friedrich Bootz
Friederike Göke
Alina Franzen
Lynn Heasley
Jutta Kirfel
Johannes Brägelmann
Sven Perner
机构：
[1] University Hospital of Bonn,Section of Prostate Cancer Research
[2] University Hospital of Bonn,Institute of Pathology
[3] University Hospital of Bonn,Center for Integrated Oncology Cologne/Bonn
[4] Pathology of the University Hospital of Luebeck,Department of Otorhinolaryngology/Head and Neck Surgery
[5] Department of Pathology,Department of Craniofacial Biology
[6] Leibniz Research Center Borstel,Department of Hematology/Oncology
[7] University Hospital of Bonn,undefined
[8] University of Colorado Anschutz Medical Campus,undefined
[9] University Hospital of Bonn,undefined
来源：
Targeted Oncology | 2016年 / 11卷
关键词：
HSC3 Cell; FGFR3 Mutation; FGFR3 Expression; Human Papilloma Virus Status; Thiazolyl Blue Tetrazolium Bromide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：631 / 642
页数：11
相关论文
共 50 条
  • [1] Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
    von Maessenhausen, Anne
    Deng, Mario
    Billig, Hannah
    Queisser, Angela
    Vogel, Wenzel
    Kristiansen, Glen
    Schroeck, Andreas
    Bootz, Friedrich
    Goeke, Friederike
    Franzen, Alina
    Heasley, Lynn
    Kirfel, Jutta
    Braegelmann, Johannes
    Perner, Sven
    TARGETED ONCOLOGY, 2016, 11 (05) : 631 - 642
  • [2] FGFR3 as a therapeutic target in squamous cell lung carcinoma
    Liao, Rachel
    Hammerman, Peter
    Sivachenko, Andrey
    Greulich, Heidi
    Getz, Gad
    Liu, Qingsong
    Gray, Nathanael
    Meyerson, Matthew
    CANCER RESEARCH, 2012, 72
  • [3] Expression and significance of FGFr3 in the squamous cell carcinoma of head and neck.
    Xu, G.
    Zhao, M.
    Gu, Z.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B369 - B369
  • [4] FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
    Koole, Koos
    Brunen, Diede
    van Kempen, Pauline M. W.
    Noorlag, Rob
    de Bree, Remco
    Lieftink, Cor
    van Es, Robert J. J.
    Bernards, Rene
    Willems, Stefan M.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3884 - 3893
  • [5] FGFR1 as a prognostic biomarker and potential therapeutic target in head and neck squamous cell carcinoma.
    Willems, Stefan M.
    Koole, Koos
    Brunen, Diede
    van Kempen, Pauline Md
    Noorlag, Rob
    Bijlsma, Rhode
    van Es, RobertJ. J.
    Lieftink, Cor
    de Bree, Remco
    Bernards, Rene
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] FGFR1 is a potential prognostic biomarker and therapeutic target in head and neck Squamous Cell Carcinoma (SCC)
    Koole, K.
    Brunen, D.
    van Kempen, P.
    Noorlag, R.
    de Bree, R.
    Lieftink, C.
    van Es, R.
    Bernards, R.
    Willems, S.
    VIRCHOWS ARCHIV, 2016, 469 : S31 - S31
  • [7] Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target
    Margaret A. Knowles
    World Journal of Urology, 2007, 25 : 581 - 593
  • [8] Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target
    Knowles, Margaret A.
    WORLD JOURNAL OF UROLOGY, 2007, 25 (06) : 581 - 593
  • [9] SET protein as a therapeutic target in head and neck squamous cell carcinoma
    Goto, Renata Nishida
    Stringhetta-Padovani, Karina
    Vitek, Michael
    Curti, Carlos
    Leopoldino, Andreia Machado
    CLINICAL CANCER RESEARCH, 2017, 23 (23)
  • [10] HER2 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
    Pollock, Netanya I.
    Grandis, Jennifer R.
    CLINICAL CANCER RESEARCH, 2015, 21 (03) : 526 - 533
12345